Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lindon

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Journal of Medicinal Chemistry|August 14, 2020
Structure-Based Design of a Bromodomain and Extraterminal Domain (BET) Inhibitor Selective for the N-Terminal Bromodomains That Retains an Anti-inflammatory and Antiproliferative PhenotypeChristopher R Wellaway, Paul Bamborough, Sharon G Bernard, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2007
Oxazolidinones as novel human CCR8 antagonistsJian Jin, Yonghui Wang, Feng Wang, et al.
Journal of Medicinal Chemistry|January 7, 2022
Design, Synthesis, and Characterization of I-BET567, a Pan-Bromodomain and Extra Terminal (BET) Bromodomain Oral CandidatePhilip G Humphreys, Stephen J Atkinson, Paul Bamborough, et al.
Journal of Medicinal Chemistry|January 7, 2020
Discovery of a Bromodomain and Extraterminal Inhibitor with a Low Predicted Human Dose through Synergistic Use of Encoded Library Technology and Fragment ScreeningChristopher R Wellaway, Dominique Amans, Paul Bamborough, et al.
Journal of Medicinal Chemistry|June 12, 2024
Structure- and Property-Based Optimization of Efficient Pan-Bromodomain and Extra Terminal Inhibitors to Identify Oral and Intravenous Candidate I-BET787David J Hirst, Paul Bamborough, Niam Al-Mahdi, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Journal of Medicinal Chemistry|August 14, 2020
Structure-Based Design of a Bromodomain and Extraterminal Domain (BET) Inhibitor Selective for the N-Terminal Bromodomains That Retains an Anti-inflammatory and Antiproliferative PhenotypeChristopher R Wellaway, Paul Bamborough, Sharon G Bernard, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2007
Oxazolidinones as novel human CCR8 antagonistsJian Jin, Yonghui Wang, Feng Wang, et al.
Journal of Medicinal Chemistry|January 7, 2022
Design, Synthesis, and Characterization of I-BET567, a Pan-Bromodomain and Extra Terminal (BET) Bromodomain Oral CandidatePhilip G Humphreys, Stephen J Atkinson, Paul Bamborough, et al.
Journal of Medicinal Chemistry|January 7, 2020
Discovery of a Bromodomain and Extraterminal Inhibitor with a Low Predicted Human Dose through Synergistic Use of Encoded Library Technology and Fragment ScreeningChristopher R Wellaway, Dominique Amans, Paul Bamborough, et al.
Journal of Medicinal Chemistry|June 12, 2024
Structure- and Property-Based Optimization of Efficient Pan-Bromodomain and Extra Terminal Inhibitors to Identify Oral and Intravenous Candidate I-BET787David J Hirst, Paul Bamborough, Niam Al-Mahdi, et al.
Pageof 2